Oncological applications of somatostatin analogues
- PMID: 2903792
Oncological applications of somatostatin analogues
Erratum in
- Cancer Res 1989 Mar 15;49(6):1618
Similar articles
-
Rationale for treating cancer with somatostatin analogs.J Endocrinol Invest. 2003;26(8 Suppl):117-9. J Endocrinol Invest. 2003. PMID: 15233226 Review. No abstract available.
-
[New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].An R Acad Nac Med (Madr). 2004;121(3):493-500. An R Acad Nac Med (Madr). 2004. PMID: 15751842 Spanish.
-
The role of somatostatin analogs in the control of tumor growth.Semin Oncol. 1994 Oct;21(5 Suppl 13):61-4. Semin Oncol. 1994. PMID: 7992085 Review. No abstract available.
-
Radiolabelled somatostatin analog therapy in prostate cancer: current status and future directions.Cancer Lett. 2006 Jul 28;239(1):21-6. doi: 10.1016/j.canlet.2005.07.020. Epub 2005 Aug 29. Cancer Lett. 2006. PMID: 16126334 Review.
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.Mol Cell Endocrinol. 2008 May 14;286(1-2):238-50. doi: 10.1016/j.mce.2007.10.006. Epub 2007 Oct 13. Mol Cell Endocrinol. 2008. PMID: 18037561 Review.
Cited by
-
Somatostatin receptors in the gastrointestinal tract in health and disease.Yale J Biol Med. 1992 Sep-Oct;65(5):493-503; discussion 531-6. Yale J Biol Med. 1992. PMID: 1340064 Free PMC article. Review.
-
Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.Dig Dis Sci. 2008 Sep;53(9):2359-65. doi: 10.1007/s10620-007-0175-9. Epub 2008 Feb 14. Dig Dis Sci. 2008. PMID: 18273705 Review.
-
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.J Clin Invest. 1994 Mar;93(3):1321-5. doi: 10.1172/JCI117090. J Clin Invest. 1994. PMID: 8132773 Free PMC article.
-
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.Br J Cancer. 1995 Jan;71(1):97-101. doi: 10.1038/bjc.1995.19. Br J Cancer. 1995. PMID: 7819058 Free PMC article. Clinical Trial.
-
Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors.Drug Des Devel Ther. 2016 Oct 25;10:3459-3470. doi: 10.2147/DDDT.S76732. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27822010 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources